SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001824293-23-000106
Filing Date
2023-04-25
Accepted
2023-04-25 13:51:11
Documents
2
Period of Report
2023-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_168244505839939.html 3  
1 FORM 3 wf-form3_168244505839939.xml 3 1732
2 EX-24.1 - POWER OF ATTORNEY RONGEN gri-form3ex241section16poa.htm EX-24 3559
  Complete submission text file 0001824293-23-000106.txt   6815
Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Rongen Roelof (Reporting) CIK: 0001698966 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40034 | Film No.: 23843775

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations